Publications of Udo Reichl

Rapp, E.; Kluge, S.; Hoffmann, M.; Benndorf, D.; Reichl, U.: Proteomic Tracing: Population Dynamics and Species Interaction of a Mucoviscidosis Relevant Bacterial Mixed Culture. PROTEOMICS 2.0 Initiative - Seminartour 2011 - Station Magdeburg, Universitätsklinikum, Magdeburg, Germany (2011)

Reichl, U.: Influenza virus production in mammalian cell culture. CeBiTec Distinguished Lecture, Bielefeld, Germany (2011)

Reichl, U.: On the complexity of virus-host cell interaction: Dynamics of Influenza A Virus Replication in Mammalian Cell Culture. 11th International Chemical and Biological Engineering Conference: CHEMPOR 2011, Lisbon, Portugal (2011)

Reichl, U.: Dynamics of Influenza A Virus Replication in Mammalian Cell Culture. BBBC Congress, Edinburgh, Scotland (2011)

Reichl, U.: Comparison of Cell Lines Considered for Influenza A virus Manufacturing. 22nd European Society for Animal Cell Technology: ESACT-Meeting on Cell Based Technologies, Vienna, Austria (2011)

Roloff, C.; Öncül, A.; Thevenin, D.; Genzel, Y.; Reichl, U.: Simulation der Kultivierung adhärenter Zellen in Wave-Bioreaktoren. Bioverfahrenstechnik an Grenzflächen: DECHEMA Tagung, Potsdam, Germany (2011)

Rüger, M.; Siewert, C.; Kluge, S.; Hoffmann, M.; Benndorf, D.; Rapp, E.; Reichl, U.: Flow cytometric monitoring of a three-species mixed bacterial community relevant for Cystic Fibrosis. 5th Conference Analysis of Microbial Cells at Single Cell Level, Carry le Rouet, France (2011)

Frensing, T.; Seitz, C.; Heynisch, B.; Reichl, U.: Influence of Host Cell Defence during Influenza Vaccine Production in MDCK Cells. Vaccine Technology III, Puerto Vallarta, Mexiko (2010)

Heynisch, B.; Frensing, T.; Seitz, C.; Reichl, U.: Induction of innate immunity signaling pathways in MDCK cells and their relevance in a bioprocess for influenza vaccine production. Molecular Interactions 2010, Berlin (2010)

Kluge, S.; Vester, D.; Rapp, E.; Genzel, Y.; Reichl, U.: Virus-Wirtszell-Interaktion bei der Produktion von Influenza A Impfstoff in tierischer Zellkultur: Aenderungen des Proteoms von Produktionszelllinien. ProcessNet-Jahrestagung 2010 und 28. DECHEMA-Jahrestagung der Biotechnologen, Aachen (2010)

Lagoda, A.; Genzel, Y.; Reichl, U.: Gene-specific transcription \& replication dynamics during human influenza A virus production. ESBES 2010, Bologna, Italy (2010)

Lagoda, A.; Hoffmann, D.; Vester, D.; Seitz, C.; Genzel, Y.; Reichl, U.: Quantitative real time-PCR-assay for the analysis of gene-specific human influenza A virus transcription \& replication dynamics. qPCR 2010, Wien, Austria (2010)

Öncül, A.; Genzel, Y.; Reichl, U.; Thevenin, D.: Flow characterization and two-population simulation in wave bioreactors using Computational Fluid Dynamics. Bioprozessorientiertes Anlagendesign, Nürnberg, Germany (2010)

Rapp, E.; Hennig, R.; Roedig, J.; Reichl, U.: Towards High-Throughput Characterization of Carbohydrates Using a Capillary DNA-Sequencer. Colloqium at the MPI of Colloids and Interfaces, Dahlem/Berlin, Germany (2010)

Rapp, E.; Hennig, R.; Roedig, J.; Schwarzer, J.; Reichl, U.: Glycosylation Pattern Analysis of Viral Antigens. 1st Workshop European Network on Viral Vaccine Processes (ENVVP), Dechema Haus, Frankfurt, Germany (2010)

Reichl, U.: Metabolics and modeling to improve bioprocessing. ACTIP Meeting, Penzberg, Germany (2010)

Reichl, U.: New Assay Platforms-a subjective selection. 1st Workshop on European Network on Viral Vaccine Processes: ENVVP, Franfurt am Main, Germany (2010)

Riedele, C.; Reichl, U.: Growth Dynamics of a 3-Species Mixed Culture after an Antibiotic Pulse – Analyzed on the Single Species Level. 8th European Symposium on Biochemical Engineering Science (ESBES), Bologna, Italy (2010)

Seitz, C.; Frensing, T.; Heynisch, B.; Reichl, U.: Einfluss der zelleigenen Pathogenabwehr auf die Influenza-Impfstoffproduktion in MDCK-Zellen. Dechema Jahrestagung, Aachen, Germany (2010)

Wolff, M.; Opitz, L.; Siewert, C.; Hansen, S. P.; Faber, R.; Reichl, U.: Downstream processing of cell culture derived Vaccinia and influenza virus particles. Vaccine Production & Manufacturing, Amsterdam, The Netherlands (2010)